{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T22:34:09Z","timestamp":1783463649199,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,5,13]],"date-time":"2011-05-13T00:00:00Z","timestamp":1305244800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1748-717x-6-46","type":"journal-article","created":{"date-parts":[[2011,5,13]],"date-time":"2011-05-13T14:17:21Z","timestamp":1305296241000},"source":"Crossref","is-referenced-by-count":9,"title":["Outcome of thyroid associated ophthalmopathy treated by radiation therapy"],"prefix":"10.1186","volume":"6","author":[{"given":"Mirna","family":"Abboud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Arabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Salti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fady","family":"Geara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,13]]},"reference":[{"key":"371_CR1","first-page":"651","volume":"7","author":"G Forbes","year":"1986","unstructured":"Forbes G, Gorman CA, Brennan MD, Gehring DG, Ilstrup DM, Earnest F: Ophthalmopathy of Graves' disease: computerized volume measurements of the orbital fat and muscle. A J Neuroradiol 1986, 7: 651-657.","journal-title":"A J Neuroradiol"},{"key":"371_CR2","first-page":"737","volume":"4","author":"G Forbes","year":"1983","unstructured":"Forbes G, Gorman CA, Gehring DG, Brennan MD, Jackson IT: Computer analysis of orbital fat and muscle volumes in Graves' ophthalmopathy. A J Neuroradiol 1983, 4: 737-742.","journal-title":"A J Neuroradiol"},{"key":"371_CR3","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/1043-2760(90)90095-K","volume":"1","author":"WM Wiersinga","year":"1990","unstructured":"Wiersinga WM: Immunosuppressive treatment of Graves' ophthalmopathy. Trends Endocrinol Metab 1990, 1: 377-381. 10.1016\/1043-2760(90)90095-K","journal-title":"Trends Endocrinol Metab"},{"key":"371_CR4","first-page":"747","volume":"14","author":"HB Burch","year":"1993","unstructured":"Burch HB, Wartofsky L: Graves' ophthalmopathy: current concepts regarding pathogenesis and management. Endocr Rev 1993, 14: 747-793.","journal-title":"Endocr Rev"},{"key":"371_CR5","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1055\/s-0029-1211086","volume":"97","author":"L Bartalena","year":"1991","unstructured":"Bartalena L, Marcocci C, Bogazzi F, Bruno-Bossio G, Pinchera A: Glucocorticoid therapy of Graves' ophthalmopathy. Exp Clin Endocrinol 1991, 97: 320-328. 10.1055\/s-0029-1211086","journal-title":"Exp Clin Endocrinol"},{"key":"371_CR6","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1210\/er.21.2.168","volume":"21","author":"L Bartalena","year":"2000","unstructured":"Bartalena L, Pinchera A, Marcocci C: Management of Graves' ophthalmopathy: reality and perspectives. Endocr Rev 2000, 21: 168-199. 10.1210\/er.21.2.168","journal-title":"Endocr Rev"},{"key":"371_CR7","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1089\/thy.1998.8.439","volume":"8","author":"L Bartalena","year":"1998","unstructured":"Bartalena L, Marcocci C, Manetti L, Tanda ML, Dell'Unto E, Rocchi R, Cartei F, Pinchera A: Orbital radiotherapy for Graves' ophthalmopathy. Thyroid 1998, 8: 439-441. 10.1089\/thy.1998.8.439","journal-title":"Thyroid"},{"key":"371_CR8","volume-title":"Thyroid-Associated Ophthalmopathy: Treatment","author":"R Ronald","year":"1997","unstructured":"Ronald R: Reed. In Thyroid-Associated Ophthalmopathy: Treatment. Volume Chapter 19. 2nd edition. Edited by: Stephen A. Falk. Lippincott-Raven Publishers, Philadelphia; 1997.","edition":"2"},{"key":"371_CR9","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1055\/s-0029-1211088","volume":"9","author":"C Marcocci","year":"1991","unstructured":"Marcocci C, Bartalena L, Bogazzi F, Bruno-Bossio G, Pinchera A: Role of orbital radiotherapy in the treatment of Graves' ophthalmopathy. Exp Clin Endocrinol 1991, 9: 332-337.","journal-title":"Exp Clin Endocrinol"},{"key":"371_CR10","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1136\/bmj.329.7462.385","volume":"329","author":"Tom Cawood","year":"2004","unstructured":"Cawood Tom, Moriarty Paul, O'Shea Donal: Recent developments in thyroid eye disease. BMJ 2004, 329: 385-390. 10.1136\/bmj.329.7462.385","journal-title":"BMJ"},{"key":"371_CR11","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/S0025-6196(12)65533-5","volume":"63","author":"J Morris","year":"1988","unstructured":"Morris J, Hay ID, Nelson RE, Jiang Nai S: Clinical utility of thyrotropin receptor antibody assays: comparison of radioreceptor and bioassay methods. Mayo Clin Proc 1988, 63: 707-712.","journal-title":"Mayo Clin Proc"},{"key":"371_CR12","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1136\/bjo.81.12.1080","volume":"81","author":"K Kazuo","year":"1997","unstructured":"Kazuo K, Fujikado T, Ohmi G, Hosoba J, Tano Y: Value of thyroid stimulating antibody in the diagnosis of thyroid associated ophthalmopathy of euthyroid patients. Br J Ophthalmol 1997, 81: 1080-1083. 10.1136\/bjo.81.12.1080","journal-title":"Br J Ophthalmol"},{"key":"371_CR13","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1136\/bjo.84.1.103","volume":"84","author":"K Ohtsuka","year":"2000","unstructured":"Ohtsuka K, Hashimoto M: Serum levels of soluble Fas in patients with Graves' ophthalmopathy. Br J Ophthalmol 2000, 84: 103-106. 10.1136\/bjo.84.1.103","journal-title":"Br J Ophthalmol"},{"key":"371_CR14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1530\/eje.0.1460153","volume":"146","author":"P Vestergaard","year":"2002","unstructured":"Vestergaard P: Smoking and thyroid disorders--a meta-analysis. Eur J Endocrinol 2002, 146: 153-61. 10.1530\/eje.0.1460153","journal-title":"Eur J Endocrinol"},{"key":"371_CR15","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1365-2265.1994.tb02445.x","volume":"40","author":"RA Metcalfe","year":"1994","unstructured":"Metcalfe RA, Weetman AP: Stimulation of extraocular muscle fibroblasts by cytokines and hypoxia: possible role in thyroid associated ophthalmopathy. Clin Endocrinol 1994, 40: 67-72. 10.1111\/j.1365-2265.1994.tb02445.x","journal-title":"Clin Endocrinol"},{"key":"371_CR16","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1210\/jc.82.7.2244","volume":"82","author":"LC Hofbauer","year":"1997","unstructured":"Hofbauer LC, Mu\u00c8hlberg T, Ko\u00c8nig A, Heufelder G, Schworm H-D, Heufelder AE: Soluble interleukin-1 receptor antagonist serum levels in smokers and nonsmokers with Graves' ophthalmopathy undergoing orbital radiotherapy. J Clin Endocrinol Metab 1997, 82: 2244-2247. 10.1210\/jc.82.7.2244","journal-title":"J Clin Endocrinol Metab"},{"key":"371_CR17","first-page":"632","volume-title":"Cigarette Smoking and Treatment Outcomes in Graves Ophthalmopathy: Annals of internal medicine","author":"L Bartalena","year":"1998","unstructured":"Bartalena L, Marcocci C, Tanda ML, Manetti L, Dell'Unto E, Bartolomei MP, Nardi M, Martino E, Pinchera A: Cigarette Smoking and Treatment Outcomes in Graves Ophthalmopathy: Annals of internal medicine. 1998, 129: 632-635."},{"key":"371_CR18","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1046\/j.1365-2265.1999.00843.x","volume":"51","author":"C Marcocci","year":"1999","unstructured":"Marcocci C, Bruno-Bossio G, Manetti L, Tanda ML, Miccoli P, Iacconi P, Bartolomei MP, Nardi M, Pinchera A, Bartalena L: The course of Graves' ophthalmopathy is not influenced by near-total thyroidectomy: a case-control study. Clin Endocrinol (Oxf) 1999, 51: 503-508. 10.1046\/j.1365-2265.1999.00843.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"371_CR19","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1056\/NEJM199801083380201","volume":"338","author":"L Bartalena","year":"1998","unstructured":"Bartalena L, Marcocci C, Bogazzi F, Manetti L, Tanda ML, Dell'Unto E, Bruno-Bossio G, Nardi M, Bartolomei MP, Lepri A, Rossi G, Martino E, Pinchera A: Relation between therapy for hyperthyroidism and the course of Graves'ophthalmopathy. N Engl J Med 1998, 338: 73-78. 10.1056\/NEJM199801083380201","journal-title":"N Engl J Med"},{"key":"371_CR20","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1056\/NEJM199801083380209","volume":"338","author":"WM Wiersinga","year":"1998","unstructured":"Wiersinga WM: Preventing Graves'ophthalmopathy. N Engl J Med 1998, 338: 121-122. 10.1056\/NEJM199801083380209","journal-title":"N Engl J Med"},{"key":"371_CR21","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1136\/bjo.87.6.773","volume":"87","author":"A Eckstein","year":"2003","unstructured":"Eckstein A, Quadbeck B, Mueller G, Rettenmeier AW, Hoermann R, Mann K, Steuhl P, Esser J: Impact of smoking on the response to treatment of thyroid associated ophthalmopathy. Br J Ophthalmol 2003, 87: 773-6. 10.1136\/bjo.87.6.773","journal-title":"Br J Ophthalmol"},{"key":"371_CR22","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1530\/eje.0.1360599","volume":"136","author":"C Spitzweg","year":"1997","unstructured":"Spitzweg C, Joba W, Hunt N, Heufelder AE: Analysis of human thyrotropin receptor gene expression and immunoreactivity in human orbital tissue. Eur J Endocrinol 1997, 136: 599-607. 10.1530\/eje.0.1360599","journal-title":"Eur J Endocrinol"},{"key":"371_CR23","first-page":"154","volume":"121","author":"JP Kriss","year":"1989","unstructured":"Kriss JP, Petersen IA, Donaldson SS, McDougall IR: Supervoltage orbital radiotherapy for progressive Graves'opthalmopathy: results of a twenty year experience. Acta Endocrinol (Copenh) 1989, 121: 154-159.","journal-title":"Acta Endocrinol (Copenh)"},{"key":"371_CR24","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/0360-3016(90)90532-O","volume":"19","author":"IA Petersen","year":"1990","unstructured":"Petersen IA, Kriss JP, McDougall IR, Donaldson S: Prognostic factors in the radiotherapy of Graves' ophthalmopathy. Int J Radiat Oncol Biol Phys 1990, 19: 259-264.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"371_CR25","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1210\/jc.85.1.102","volume":"85","author":"GJ Kahaly","year":"2000","unstructured":"Kahaly GJ, Rosler H-P, Pitz S, Hommel G: Low- versus high dose radiotherapy for Graves' ophthalmopathy: a randomized, single blind trial. J Clin Endocrinol Metab 2000, 85: 102-108. 10.1210\/jc.85.1.102","journal-title":"J Clin Endocrinol Metab"},{"key":"371_CR26","first-page":"301","volume-title":"Radiotherapy of Graves' ophthalmopathy","author":"A Pinchera","year":"1984","unstructured":"Pinchera A, Bartalena L, Chiovato L, Marcocci C: Radiotherapy of Graves' ophthalmopathy. Edited by: Gorman CA, Waller RR, Dyer JA. The Eye and Orbit in Thyroid Disease. Raven Press, New York; 1984:301-316."},{"key":"371_CR27","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1210\/jcem-37-2-276","volume":"37","author":"SS Donaldson","year":"1973","unstructured":"Donaldson SS, Bagshaw MA, Kriss JP: Supervoltage orbital radiotherapy for Graves' ophthalmopathy. J Clin Endocrinol Metab 1973, 37: 276-285. 10.1210\/jcem-37-2-276","journal-title":"J Clin Endocrinol Metab"},{"key":"371_CR28","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1210\/jcem-56-6-1139","volume":"56","author":"L Bartalena","year":"1983","unstructured":"Bartalena L, Marcocci C, Chiovato L, Laddaga M, Lepri G, Andreani D, Cavallacci G, Baschieri L, Pinchera A: Orbital cobalt irradiation combined with systemic corticosteroid for Graves' ophthalmopathy: comparison with systemic corticosteroids alone. J Clin Endocrinol Metab 1983, 56: 1139-44. 10.1210\/jcem-56-6-1139","journal-title":"J Clin Endocrinol Metab"},{"key":"371_CR29","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/S0140-6736(00)02165-6","volume":"355","author":"MP Mourits","year":"2000","unstructured":"Mourits MP, van Kempen-Harteveld ML, Garcia MB, Koppeschaar HP, Tick L, Terwee CB: Radiotherapy for Graves' orbitopathy: randomized placebo-controlled study. Lancet 2000, 355: 1505-9. 10.1016\/S0140-6736(00)02165-6","journal-title":"Lancet"},{"key":"371_CR30","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/S0360-3016(01)01699-6","volume":"51","author":"SD Marquez","year":"2001","unstructured":"Marquez SD, Lum BL, McDougall IR, Katkuri S, Levin PS, MacManus M, Donaldson SS: Long-term results of irradiation for patients with progressive Graves' ophthalmopathy. Int J Radiat Oncol Biol Phys 2001, 51: 766-74. 10.1016\/S0360-3016(01)01699-6","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"371_CR31","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/j.ophtha.2003.12.054","volume":"111","author":"IM Wakelkamp","year":"2004","unstructured":"Wakelkamp IM, Tan H, Saeed P, Schlingemann RO, Verbraak FD, Blank LE, Prummel MF, Wiersinga WM: Orbital irradiation for Graves' ophthalmopathy: Is it safe? A long-term follow-up study. Ophthalmology 2004, 111: 1557-62. 10.1016\/j.ophtha.2003.12.054","journal-title":"Ophthalmology"},{"key":"371_CR32","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/eye.2000.199","volume":"14","author":"RLJ Van Ruyven","year":"2000","unstructured":"Van Ruyven RLJ, van den Bosch WA, Mulder PG, Eijkenboom WM, Paridaens AD: The effect of retrobulbar irradiation on exophthalmos, ductions, and soft tissue sign in Graves' ophthalmopathy: a retrospective analysis of 90 cases. Eye 2000, 14: 761-764.","journal-title":"Eye"},{"key":"371_CR33","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/0360-3016(89)90073-4","volume":"17","author":"HM Sandler","year":"1989","unstructured":"Sandler HM, Rubenstein JH, Fowble BL, Sergott RC, Savino PJ, Bosley TM: Results of radiotherapy for thyroid ophthalmopathy. Int J Radiat Oncol Biol Phys 1989, 17: 823-827. 10.1016\/0360-3016(89)90073-4","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"371_CR34","first-page":"7","volume":"26","author":"C Marcocci","year":"2003","unstructured":"Marcocci C: Usefulness of orbital radiotherapy for Graves' ophthalmopathy: evidence in favor. J Endocrinol Invest 2003, 26: 7-9.","journal-title":"J Endocrinol Invest"},{"key":"371_CR35","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1159\/000309924","volume":"197","author":"WM Wiersinga","year":"1988","unstructured":"Wiersinga WM, Smit T, Schuster-Uittenhoeve ALJ, van der Gaag R, Koornneef L: Therapeutic outcome of prednisone medication and of orbital irradiation in patients with Graves' ophthalmopathy. Ophthalmologica 1988, 197: 75-84. 10.1159\/000309924","journal-title":"Ophthalmologica"},{"key":"371_CR36","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1089\/105072502753600223","volume":"12","author":"L Bartalena","year":"2002","unstructured":"Bartalena L, Marcocci C, Tanda ML, Rocchi R, Mazzi B, Barbesino G, Pinchera A: Orbital radiotherapy for Graves' ophthalmopathy. Thyroid 2002, 12: 245-250. 10.1089\/105072502753600223","journal-title":"Thyroid"},{"key":"371_CR37","volume-title":"Oxford textbook of endocrinology and diabetes","author":"MF Prummel","year":"2002","unstructured":"Prummel MF, Wiersinga WM: Graves' ophthalmopathy and dermopathy. In Oxford textbook of endocrinology and diabetes. 1st edition. Edited by: Wass JAH, Shalet SM. Eds Oxford: Oxford University Press; 2002.","edition":"1"},{"issue":"1","key":"371_CR38","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0950-351X(05)80333-7","volume":"6","author":"RS Bahn","year":"1992","unstructured":"Bahn RS, Bartley GB, Gorman CA: Emergency treatment of Graves' ophthalmopathy. Baillieres Clin Endocrinol Metab 1992,6(1):95-105. 10.1016\/S0950-351X(05)80333-7","journal-title":"Baillieres Clin Endocrinol Metab"},{"key":"371_CR39","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0950-351X(97)80738-0","volume":"11","author":"L Bartalena","year":"1997","unstructured":"Bartalena L, Marcocci C, Pinchera A: Treating severe Graves' ophthalmopathy. Bailliere's Clin Endocrinol Metab 1997, 11: 521-536. 10.1016\/S0950-351X(97)80738-0","journal-title":"Bailliere's Clin Endocrinol Metab"},{"issue":"8","key":"371_CR40","doi-asserted-by":"publisher","first-page":"3562","DOI":"10.1210\/jc.86.8.3562","volume":"86","author":"Claudio Marcocci","year":"2001","unstructured":"Marcocci Claudio, Bartalena Luigi, Laura Tanda Maria, Manetti Luca, Dell'Unto Enrica, Rocchi Roberto, Barbesino Giuseppe, Mazzi Barbara, Pia Bartolomei Maria, Lepri Paola, Cartei Francesco, Nardi Marco, Pinchera Aldo: Comparison of the Effectiveness and Tolerability of Intravenous or Oral Glucocorticoids Associated with Orbital Radiotherapy in the Management of Severe Graves' Ophthalmopathy: Results of a Prospective, Single-Blind, Randomized Study. The Journal of Clinical Endocrinology & Metabolism 2001,86(8):3562-3567. 10.1210\/jc.86.8.3562","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"371_CR41","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/BF03347943","volume":"14","author":"C Marcocci","year":"1991","unstructured":"Marcocci C, Bartalena L, Bogazzi F, Bruno-Bossio G, Lepri A, Pinchera A: Orbital radiotherapy combined with high-dose systemic glucocorticoids for Graves' ophthalmopathy is more effective than orbital radiotherapy alone: results of a prospective study. J Endocrinol Invest 1991, 14: 853-860.","journal-title":"J Endocrinol Invest"},{"key":"371_CR42","first-page":"322","volume":"11","author":"Ng CM","year":"2005","unstructured":"CM Ng, Yuen HK, Choi KL, Chan MK, Yuen KT, Ng YW, Tiu SC: Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate-to-severe Graves' ophthalmopathy: a preliminary study. Hong Kong Med J 2005, 11: 322-30.","journal-title":"Hong Kong Med J"},{"key":"371_CR43","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0002-9394(02)01970-0","volume":"135","author":"K Ohtsuka","year":"2003","unstructured":"Ohtsuka K, Sato A, Kawaguchi S, Hashimoto M, Suzuki Y: Effect of steroid pulse therapy with and without radiotherapy on Graves' ophthalmopathy. Am J Ophthalmol 2003, 135: 285-90. 10.1016\/S0002-9394(02)01970-0","journal-title":"Am J Ophthalmol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1748-717X-6-46.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1748-717X-6-46\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1748-717X-6-46.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T23:55:23Z","timestamp":1548201323000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/1748-717X-6-46"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,13]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["371"],"URL":"https:\/\/doi.org\/10.1186\/1748-717x-6-46","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,13]]},"article-number":"46"}}